Sign In

Mayo Pujols

Chief Executive Officer at Andelyn Biosciences

Mayo Pujols is a biopharmaceutical executive with over 25 years of experience in cell and gene therapy manufacturing. He served as Chief Executive Officer of Andelyn Biosciences from May 2020 until June 2022, leading the company's expansion into a full-service gene therapy contract development and manufacturing organization (CDMO).124 His LinkedIn username is mayopujols.15

Key Career Highlights

  • Andelyn Biosciences: As CEO, he oversaw the development of viral vector manufacturing capabilities and supported over 450 clinical batches and 75 clinical trials.12
  • Prior Roles: Held leadership positions at Novartis (VP of Global CAR-T Operations), Celgene (VP of Global CAR-T Operations), Merck, and MedImmune.134
  • Current Position: Chief Technical Officer at Rocket Pharmaceuticals since July 2022, focusing on gene therapy manufacturing and commercialization.14

Education

  • Undergraduate degree from Stevens Institute of Technology
  • Graduate degree from Columbia University’s Fu Foundation School of Engineering & Applied Science.15

His expertise spans cGMP manufacturing, process development, and scaling cell/gene therapies from clinical to commercial stages.134

Highlights

Oct 19 · prnewswire.com
Curate Biosciences Adds Mayo Pujols to its Board of Directors
Rocket Pharmaceuticals Appoints Mayo Pujols as Chief Technical ...
May 23 · marketscreener.com
Mayo Pujols: Positions, Relations and Network - MarketScreener

Related Questions

What are Mayo Pujols' main responsibilities at Rocket Pharmaceuticals, Inc?
How did Mayo Pujols transition from MedImmune LLC to Andelyn Biosciences?
What are some notable achievements of Mayo Pujols in the biotechnology industry?
What is the significance of Mayo Pujols' role at Curate Biosciences?
How has Mayo Pujols' career evolved over the past two decades?
Mayo Pujols
Mayo Pujols, photo 1
Mayo Pujols, photo 2
Add to my network